earnings
confidence high
sentiment neutral
materiality 0.75
Elevance Health Q4 2024 adjusted EPS $3.84, FY 2025 guidance $34.15-$34.85; dividend raised 5% to $1.71
Elevance Health, Inc.
2024-FY EPS reported
$25.68
revenue$177,011,000,000
- Q4 operating revenue $45.0B (+6% YoY); FY revenue $175.2B (+3%).
- Q4 GAAP EPS $1.81; adjusted EPS $3.84. FY GAAP EPS $25.68; adjusted EPS $33.04.
- Health Benefits Q4 operating margin 0.6% (down from 2.1% YoY) on higher Medicaid cost trend.
- Carelon Q4 adjusted operating margin 5.3% (up from 4.8% YoY); FY adjusted margin 5.8%.
- FY 2025 adjusted EPS guidance $34.15-$34.85; dividend raised 5% to $1.71, payable 3/25/25.